A detailed history of Formidable Asset Management, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Formidable Asset Management, LLC holds 33,359 shares of VKTX stock, worth $1.31 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
33,359
Previous 25,720 29.7%
Holding current value
$1.31 Million
Previous $1.36 Million 54.88%
% of portfolio
0.35%
Previous 0.23%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$49.84 - $70.47 $380,727 - $538,320
7,639 Added 29.7%
33,359 $2.11 Million
Q2 2024

Aug 08, 2024

BUY
$47.39 - $80.2 $290,595 - $491,786
6,132 Added 31.3%
25,720 $1.36 Million
Q1 2024

May 15, 2024

BUY
$17.4 - $94.5 $340,831 - $1.85 Million
19,588 New
19,588 $1.61 Million

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $3.01B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Formidable Asset Management, LLC Portfolio

Follow Formidable Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Formidable Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Formidable Asset Management, LLC with notifications on news.